Influenza vaccines: Why are we missing high-risk patients?

Journal of General Internal Medicine

Volumn 17, Issue 9, 2002, Pages 736-737

  Perl, Trish M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG EFFECT; DRUG TOLERANCE; EDITORIAL; EPIDEMIC; HEALTH CARE SYSTEM; HIGH RISK PATIENT; HUMAN; IMMUNOGENICITY; INFLUENZA; INFLUENZA VACCINATION;

HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; PHYSICIAN'S PRACTICE PATTERNS; RISK FACTORS; VACCINATION;

EID: 0036046907     PISSN: 08848734     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1497.2002.20750.x     Document Type: Editorial

References (9)

1. Surveillance for influenza-United States, 1994-95, 1995-96, and 1996-97 seasons
2. Prevention and control of influenza. Role of vaccine
3. Reactogenicity, immunogenicity and antibody persistance in adults given inactivated influenza virus vaccine-1978
4. The effectiveness of vaccination against influenza in healthy, working adults
5. Association of influenza immunization with reduction in mortality in an elderly population. A prospective study
6. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature
7. Mailed reminders for area-wide influenza immunization: A randomized controlled trial
8. A national survey of physician practices regarding influenza vaccine